Entries by Dante Ferrarini

SMART Biotechnologies, Inc. Announces the Appointment of Thomas J. Bigger as New Company President

GAINESVILLE, FL – January 8, 2013 SMART Biotechnologies, Inc., the newest subsidiary of the medical technology innovator, Xhale, Inc., has just appointed Mr. Thomas J. Bigger as its new president. Mr. Bigger comes to SMART with over 20 years of experience building shareholder value in pharmaceutical companies globally. Mr. Bigger most recently held the positions […]

Assurance Biosense Issued European and Japanese Patents for Unique Pulse Oximetry Sensors and Monitoring Systems

Glastonbury, CT – November 16, 2012 Assurance Biosense, Inc., a wholly owned subsidiary of Xhale, Inc., a leading innovator in patient safety solutions, announced today the recent issuance of European Patent EP1513443 and Japanese Patent JP5134367, which include claims to novel sensors, devices, systems and methodsfor monitoring pulse oximetry. The European patent, entitled “Perfusion Monitor […]

Xhale Completes Spin-Off of Assurance Biosense

New wholly owned subsidiary, Assurance Biosense, Inc., will focus on PPG related products in rapidly evolving patient monitoring segment. Gainesville, FL — Xhale, Inc. announced today the completion of the spin-off of Assurance Biosense, Inc., a wholly owned subsidiary of Xhale, Inc. The company is located in Glastonbury Connecticut, and is focused on the commercialization […]

Xhale Awarded National Institute of Drug Abuse (NIDA) Grant for Further Development of Innovative Breath-Based SMART® Adherence Tool.

GAINESVILLE, FL – August 22, 2012 Xhale, Inc. announced today it has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART® (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies. In 2007, […]

Xhale Completes NIH-Funded Study on SMART™ Adherence Monitoring System

Xhale, Inc. announced today the successful completion of an NIH-funded study of usability on its SMART™ Medication Adherence Monitoring System. Gainesville, FL July 26, 2012 — Xhale, Inc. announced today the successful completion of a study sponsored by the National Institutes of Health (NIH) to assess the usability of the SMART™ Medication Adherence System. SMART™ […]

Xhale Issued U.S Patent for Breath-Based Closed-Loop Propofol Monitoring

Xhale, Inc. announced today the issuance of U.S. patent 8,211,035, disclosing a non-invasive method of monitoring and controlling propofol and other IV-administered agents utilizing a breath detection system. Gainesville, FL July 3, 2012 Xhale, Inc. announced today the issuance of U.S. Patent 8,211,035, disclosing methods and apparatuses for the detection, quantitation, and trending of intravenous […]

Xhale Issued European Patent for Novel Nasal Pulse Oximeter Sensor Configuration

European patent EP1706025 discloses methods and probes for monitoring PPG and pulse oximetry signals across the nasal septum, optionally configured with a cannula to supply oxygen and/or a carbon dioxide sensor. GAINESVILLE, FL – May 9, 2012 Xhale, Inc., a leading innovator in patient safety solutions, announced today the issuance of European Patent EP1706025, which […]

Xhale Completes Spin Off of SMART Biotechnologies

GAINESVILLE, FL – Oct. 1, 2012 – Xhale, Inc. Xhale, Inc. announced today the completion of the spin off of SMART Biotechnologies, a wholly owned subsidiary of Xhale, Inc. The company is located at the Xhale headquarters in Gainesville, Florida, and is focused on the development of a breakthrough technology for measuring, monitoring, reporting and […]

Xhale Issued Japanese Patent for Monitoring Drug Compliance

Xhale, Inc. announced today the issuance of Japanese patent 4773019, disclosing a method for monitoring drug compliance by detecting markers, such as odors, upon breath exhalation after medication is taken. Gainesville, FL July 1, 2011 Xhale, Inc. announced today the issuance of Japanese Patent 4773019, disclosing methods and apparatuses for monitoring drug compliance by detecting […]

Xhale Issued U.S. Patent for Non-invasive Monitoring of Blood Glucose Using Exhaled Breath

Xhale, Inc. announced today the issuance of U.S. patent 7,914,460, disclosing a system and method for non-invasive monitoring of glucose concentrations in blood through the analysis of exhaled breath condensate. Gainesville, FL (PRWEB) May 31, 2011 — Xhale, Inc. announced today the issuance of U.S. patent 7,914,460, disclosing a system and method for noninvasive monitoring […]